Evonik invests in Irish medical device company Vivasure Medical

Creative industrial group Evonik have invested in the Ireland based medical device company, Vivasure Medical.

The investment allows Evonik to utilise Vivasure’s knowledge in polymers for pharma and medical device applications.

Bernhard Mohr, head of venture capital at Evoknik said: “Solutions for health and medical technology are among the key growth areas for Evonik. Due to our technological competence in these areas and our existing product portfolio, Vivasure Medical fits strategically with Evonik.”

The Vivasure Closure Device is the first product from the company’s PerQseal technology platform, and is an approved bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures. Worldwide these minimally invasive procedures are becoming prevalent in operations. In some areas they are already established as the standard. The reason: only small incisions are required to perform minimally invasive procedures, which are easier on patients.   

Gerard Brett, chief executive officer and one of the founders of Vivasure Medical said: “The Vivasure closure device is designed to be easy to use, allowing the surgeon to provide a complete repair at the access site, without leaving metal implants, sutures, or exogenous tissue behind. Our goal is improved clinical outcomes, faster recovery times and better therapeutic results for patients over the open-surgery alternative.”   

A bioabsorbable polymer from Evonik is being utilised by Vivasure Medical. Evonik claimed the polymer supposedly offers more possibilities for targeting and timing therapies with greater precisions at lower dosages – more efficacy and fewer side-effects.